INNATE IMMUNITY AND CARDIO-RENAL RISK IN STAGE 2-5 CKD PATIENTS

被引：0
|
作者：
Zoccali, C.
Pizzini, P.
Leonardis, D.
Torino, C.
Postorino, M.
D'Arrigo, G.
Tripepi, G.
Mallamaci, F.
机构：
[1] CNR IFC, Reggio Di Calabria, Italy
[2] Nephrol Dialysis & Transplantat Unit, Reggio Di Calabria, Italy
来源：
JOURNAL OF HYPERTENSION | 2017年 / 35卷
关键词：
D O I：
10.1097/01.hjh.0000522976.62696.2d
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
OP.1A.02
引用
收藏
页码：E1 / E1
页数：1
相关论文
共 50 条
  • [1] CKD associated with Type 2 Diabetes Reducing the cardio-renal Risk with nsMR Antagonists
    von Graetz, Philipp Graetzel
    DIABETES STOFFWECHSEL UND HERZ, 2022, 31 (06): : 359 - 360
  • [2] HYPERTENSION MANAGEMENT IN CKD: UPDATE FOR BETTER CARDIO-RENAL OUTCOMES
    Masuda, Takahiro
    Nagata, Daisuke
    JOURNAL OF HYPERTENSION, 2023, 41 : E162 - E162
  • [3] Calcium antagonists - Effects on cardio-renal risk in hypertensive patients
    Nathan, S
    Pepine, CJ
    Bakris, GL
    HYPERTENSION, 2005, 46 (04) : 637 - 642
  • [4] FGF23 AND ASYMMETRICAL DIMETHYLARGININE (ADMA) ARE INTERACTIVE FACTORS IN THE HIGH RISK FOR CKD PROGRESSION IN STAGE 2-5 CKD PATIENTS
    Tripepi, Giovanni
    Tripepi, Giovanni
    Leonardis, Daniela
    Postorino, Maurizio
    Enia, Giuseppe
    Zoccali, Carmine
    Mallamaci, Francesca
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 19 - 19
  • [5] First Cardio-Renal Events in Patients with Type 2 Diabetes and Subsequent Risk of Death: An Analysis of Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE)
    Jhund, Pardeep S.
    Mcmurray, John J. V.
    Brunel, Patrick
    Chaturvedi, Nishi
    Desai, Akshay S.
    Finn, Peter V.
    Haffner, Steven M.
    Solomon, Scott D.
    Weinrauch, Larry A.
    Pfeffer, Marc A.
    DIABETES, 2014, 63 : A350 - A350
  • [6] PULMONARY HYPERTENSION REFLECTS THE SEVERITY OF MYOCARDIAL DISEASE IN STAGE 2-5 CKD PATIENTS
    Bolignano, Davide
    Tripepi, Rocco
    Leonardis, Daniela
    Mallamaci, Francesca
    Zoccali, Carmine
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 356 - 357
  • [7] Lipocalin-2 Variants and Their Relationship With Cardio-Renal Risk Factors
    Li, Dahui
    Li, Haoyun
    Bauer, Carlie
    Hu, Yue
    Lewis, Joshua R.
    Xu, Aimin
    Levinger, Itamar
    Wang, Yu
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [8] Cardio-renal Syndrome in Single Ventricle Patients
    Aydin, Scott I.
    Glotzbach, Kristi
    Skversky, Amy
    Hsu, Daphne
    CIRCULATION, 2015, 132
  • [9] The problem of cardio-renal diseases in patients with gout
    Ferri, Claudio
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 : 9 - 13
  • [10] VEGF therapy improves cardio-renal pathophysiology in a novel model of CKD-HFpEF
    Chade, Alejandro
    Sitz, Rhys
    Mccarthy, Elizabeth
    Tharp, Darla
    Bidwell, Gene
    Eirin, Alfonso
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
12345